Ian Mortimer, Xenon Pharma CEO, sells $1.14m in shares President and CEO Ian Mortimer sold 25,205 common shares in multiple transactions on December 5 and December 8, 2025, for a total value of $1,142,513. The price range for these sales was between $45.03 and $46.32. The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 27, 2024. On December 5, Mortimer sold 14,375 shares at a price of $45.03.
Ian Mortimer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Ian
Contact Ian, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack